Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer

Lignende værker

• Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer
  af: Yoon, Seong-Hoon, et al.
  Udgivet: (2015)
• A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1
  af: Park, Cheol-Kyu, et al.
  Udgivet: (2021)
• A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
  af: Park, Cheol-Kyu, et al.
  Udgivet: (2019)
• Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor
  af: Kim, Woo-Jin, et al.
  Udgivet: (2015)
• Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
  af: Park, Seongho, et al.
  Udgivet: (2019)